Company sells shares, warrants through agent Rodman & Renshaw
By Devika Patel
Knoxville, Tenn., Oct. 13 - Rosetta Genomics, Ltd. said it will conduct a $1.95 million private placement of stock through agent Rodman & Renshaw, LLC.
The company will sell 2,598,002 ordinary shares at $0.75 per share. The price per share is an 37.5% discount to the Oct. 12 closing share price of $1.20.
Investors also will receive warrants for 3,897,003 shares. The series A warrants, for 2,598,002 ordinary shares, are each exercisable at $1.00 for five years. The series B warrants, for 1,299,001 ordinary shares, are each exercisable at an exercise price equal to the greater of $0.01 or NIS 0.04 per share. The series A strike price is a 16.67% discount to the Oct. 12 closing price.
Settlement is expected Oct. 18.
Rosetta Genomics develops and provides microRNA-based molecular diagnostics. It is based in Rehovot, Israel.
| Issuer: | Rosetta Genomics, Ltd.
|
| Issue: | Ordinary stock
|
| Amount: | $1,948,502
|
| Shares: | 2,598,002
|
| Price: | $0.75
|
| Warrants: | For 3,897,003 shares
|
| Warrant expiration: | Five years (series A)
|
| Warrant strike price: | $1.00 (series A)
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | Oct. 13
|
| Settlement date: | Oct. 18
|
| Stock symbol: | Nasdaq: ROSG
|
| Stock price: | $1.20 at close Oct. 12
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
